CELZ | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 0%

Liquidity 0%

Performance 10%

Performance

5 Days

3.57%

1 Month

0.29%

3 Months

-22.11%

6 Months

-20.73%

1 Year

-24.51%

2 Year

-49.21%

Key data

Stock price

$3.42

P/E Ratio

0.00

DAY RANGE

N/A - N/A

EPS

$0.00

52 WEEK RANGE

$2.90 - $10.28

52 WEEK CHANGE

-$0.24

MARKET CAP

4.657 M

YIELD

N/A

SHARES OUTSTANDING

1.338 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.37

PUBLIC FLOAT

AVERAGE 10 VOLUME

$4,788

AVERAGE 30 VOLUME

$8,288

Company detail

CEO:
Region: US
Website: creativemedicaltechnology.com
Employees: 0
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

creative medical technology holdings, inc., through its subsidiaries, engages in the stem cell research and developing applications to treat male sexual dysfunction and related issues. the company markets its erectile dysfunction (ed) treatment under the caverstem name to physicians for use with their patients suffering from ed. creative medical technology holdings, inc. was incorporated in 1998 and is based in phoenix, arizona. creative medical technology holdings, inc. is a subsidiary of creative medical health, inc.

CELZ - Creative Medical Technology Holdings Inc